Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival

被引:18
作者
Horie, Miho [1 ,2 ]
Salazar, Pascal [3 ]
Saito, Tomohito [4 ,5 ,6 ]
Binnie, Matthew [5 ]
Brock, Kristy [7 ]
Yasufuku, Kazuhiro [4 ,5 ]
Azad, Sassan [4 ]
Keshavjee, Shaf [2 ,5 ,6 ]
Martinu, Tereza [5 ]
Paul, Narinder [1 ,2 ]
机构
[1] Univ Toronto, Univ Hlth Network, Joint Dept Med Imaging, Toronto, ON, Canada
[2] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada
[3] Vital Images, Minnetonka, MN USA
[4] Univ Toronto, Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada
[5] Univ Toronto, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada
[6] Kansai Med Univ, Dept Thorac Surg, Hirakata, Osaka, Japan
[7] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA
关键词
bronchiolitis obliterans syndrome; chronic lung allograft dysfunction; computed tomography; restrictive allograft syndrome; BRONCHIOLITIS OBLITERANS SYNDROME; IDIOPATHIC PULMONARY-FIBROSIS; TRANSPLANT RECIPIENTS; COMPUTED-TOMOGRAPHY; RISK; PROGRESSION; PHENOTYPE; ONSET;
D O I
10.1111/ctr.13233
中图分类号
R61 [外科手术学];
学科分类号
摘要
Chronic lung allograft dysfunction (CLAD) is a major cause of mortality in lung transplant recipients. CLAD can be sub-divided into at least 2 subtypes with distinct mortality risk characteristics: restrictive allograft syndrome (RAS), which demonstrates increased overall computed tomography (CT) lung density in contrast with bronchiolitis obliterans syndrome (BOS), which demonstrates reduced overall CT lung density. This study aimed to evaluate a reader-independent quantitative density metric (QDM) derived from CT histograms to associate with CLAD survival. A retrospective study evaluated CT scans corresponding to CLAD onset using pulmonary function tests in 74 patients (23 RAS, 51 BOS). Two different QDM values (QDM1 and QDM2) were calculated using CT lung density histograms. Calculation of QDM1 includes the extreme edges of the histogram. Calculation of QDM2 includes the central region of the histogram. Kaplan-Meier analysis and Cox regression analysis were used for CLAD prognosis. Higher QDM values were significantly associated with decreased survival. The hazard ratio for death was 3.2 times higher at the 75th percentile compared to the 25th percentile using QDM1 in a univariate model. QDM may associate with CLAD patient prognosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis
    McInnis, Micheal C.
    Ma, Jin
    Karur, Gauri Rani
    Houbois, Christian
    Levy, Liran
    Havlin, Jan
    Fuchs, Eyal
    Tikkanen, Jussi
    Chow, Chung-Wai
    Huszti, Ella
    Martinu, Tereza
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (01)
  • [32] Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
    Verleden, Geert M.
    Godinas, Laurent
    Vos, Robin
    Verleden, Stijn E.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2022, 27 (03) : 211 - 216
  • [33] Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival
    Gallagher, Harry M.
    Sarwar, Ghulam
    Tse, Tracy
    Sladden, Timothy M.
    Hii, Esmond
    Yerkovich, Stephanie T.
    Hopkins, Peter M.
    Chambers, Daniel C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (11) : 1442 - 1448
  • [34] Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients
    Siddiqui, Atif S.
    Kumar, Gagan
    Majumdar, Tilottama
    Graviss, Edward A.
    Nguyen, Duc T.
    Goodarzi, Ahmad
    Kaleekal, Thomas
    CLINICAL TRANSPLANTATION, 2018, 32 (10)
  • [35] Restrictive chronic lung allograft dysfunction: Where are we now?
    Verleden, Stijn E.
    Ruttens, David
    Vandermeulen, Elly
    Bellon, Hannelore
    Van Raemdonck, Dirk E.
    Dupont, Lieven J.
    Vanaudenaerde, Bart M.
    Verleden, Geert
    Vos, Robin
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (05) : 625 - 630
  • [36] Novel biomarkers of chronic lung allograft dysfunction: is there anything reliable?
    Verleden, Stijn E.
    Verleden, Geert M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2022, 27 (01) : 1 - 6
  • [37] Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction
    January, Spenser E.
    Fester, Keith A.
    Bain, Karen Bennett
    Kulkarni, Hrishikesh S.
    Witt, Chad A.
    Byers, Derek E.
    Alexander-Brett, Jennifer
    Trulock, Elbert P.
    Hachem, Ramsey R.
    CLINICAL TRANSPLANTATION, 2019, 33 (10)
  • [38] Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
    Bennett, David
    Bergantini, Laura
    Ferrara, Pierluigi
    Cusi, Maria Grazia
    Scolletta, Sabino
    Montagnani, Francesca
    Paladini, Piero
    Sestini, Piersante
    Refini, Rosa Metella
    Luzzi, Luca
    Fossi, Antonella
    Bargagli, Elena
    LUNG, 2022, 200 (04) : 513 - 522
  • [39] Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction
    Belperio, John
    Palmer, Scott M.
    Weigt, S. Sam
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 : S242 - S246
  • [40] MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
    Miyahara, Naofumi
    Benazzo, Alberto
    Oberndorfer, Felicitas
    Iwasaki, Akinori
    Laszlo, Viktoria
    Dome, Balasz
    Hoda, Mir Ali
    Jaksch, Peter
    Klepetko, Walter
    Hoetzenecker, Konrad
    TRANSPLANT INTERNATIONAL, 2022, 35